tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pfizer announces Phase 2 FOURLIGHT-1 study met primary endpoint
PremiumThe FlyPfizer announces Phase 2 FOURLIGHT-1 study met primary endpoint
5d ago
Pfizer price target raised to $32 from $29 at HSBC
Premium
The Fly
Pfizer price target raised to $32 from $29 at HSBC
5d ago
District court rules federal limits to vaccines not based on science, NYT says
Premium
The Fly
District court rules federal limits to vaccines not based on science, NYT says
5d ago
BioNTech sees FY26 revenue EUR 2B-EUR 2.3B
PremiumThe FlyBioNTech sees FY26 revenue EUR 2B-EUR 2.3B
12d ago
Pfizer reports ‘positive’ results from Phase 2 study of tilrekimig
Premium
The Fly
Pfizer reports ‘positive’ results from Phase 2 study of tilrekimig
13d ago
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
13d ago
ParaZero appoints Bat-Sheva Noy as VP, global sales
PremiumThe FlyParaZero appoints Bat-Sheva Noy as VP, global sales
18d ago
Netflix upgraded, Pinterest downgraded: Wall Street’s top analyst calls
Premium
The Fly
Netflix upgraded, Pinterest downgraded: Wall Street’s top analyst calls
20d ago
Argus upgrades Pfizer to Buy, citing GLP-1 pipeline, oncology programs
Premium
The Fly
Argus upgrades Pfizer to Buy, citing GLP-1 pipeline, oncology programs
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100